MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

Search

Evolent Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

3.83 1.06

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.7800000000000002

Max

3.9

Pagrindiniai rodikliai

By Trading Economics

Pajamos

30M

-21M

Pardavimai

35M

480M

Pelno marža

-4.351

Darbuotojai

4,500

EBITDA

512K

15M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+136.8% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-02-19

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-342M

437M

Ankstesnė atidarymo kaina

2.77

Ankstesnė uždarymo kaina

3.83

Naujienos nuotaikos

By Acuity

25%

75%

138 / 360 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

Evolent Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-22 21:55; UTC

Uždarbis

Capital One Financial Posts Higher 4Q Profit As Lending Increases

2026-01-22 23:52; UTC

Uždarbis

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

2026-01-22 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

2026-01-22 23:42; UTC

Rinkos pokalbiai

Gold Edges Lower on Possible Profit-Taking -- Market Talk

2026-01-22 23:40; UTC

Rinkos pokalbiai

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

2026-01-22 23:30; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-22 23:30; UTC

Rinkos pokalbiai

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

2026-01-22 22:37; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

2026-01-22 21:59; UTC

Įsigijimai, susijungimai, perėmimai

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

2026-01-22 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2026-01-22 21:44; UTC

Uždarbis

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

2026-01-22 21:32; UTC

Įsigijimai, susijungimai, perėmimai

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

2026-01-22 21:31; UTC

Įsigijimai, susijungimai, perėmimai

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

2026-01-22 21:31; UTC

Įsigijimai, susijungimai, perėmimai

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

2026-01-22 21:30; UTC

Įsigijimai, susijungimai, perėmimai

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

2026-01-22 21:30; UTC

Uždarbis

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

2026-01-22 21:30; UTC

Įsigijimai, susijungimai, perėmimai

Capital One To Acquire Brex >COF

2026-01-22 21:13; UTC

Uždarbis

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

2026-01-22 21:11; UTC

Uždarbis

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

2026-01-22 21:11; UTC

Uždarbis

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

2026-01-22 21:10; UTC

Uždarbis

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

2026-01-22 21:06; UTC

Uždarbis

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

2026-01-22 21:05; UTC

Uždarbis

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

2026-01-22 21:05; UTC

Uždarbis

Capital One 4Q Rev $15.58B >COF

2026-01-22 21:05; UTC

Uždarbis

Capital One 4Q EPS $3.26 >COF

2026-01-22 21:05; UTC

Uždarbis

Capital One 4Q Net Interest Margin 8.26% >COF

2026-01-22 21:05; UTC

Uždarbis

Capital One 4Q Net $2.13B >COF

2026-01-22 21:05; UTC

Uždarbis

Capital One 4Q Adj EPS $3.86 >COF

2026-01-22 21:05; UTC

Uždarbis

Capital One 4Q Net Charge-Offs $3.8B >COF

2026-01-22 21:05; UTC

Uždarbis

Intuitive Surgical 4Q EPS $2.21 >ISRG

Akcijų palyginimas

Kainos pokytis

Evolent Health Inc Prognozė

Kainos tikslas

By TipRanks

136.8% į viršų

12 mėnesių prognozė

Vidutinis 9.33 USD  136.8%

Aukščiausias 16 USD

Žemiausias 5 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Evolent Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

14 ratings

13

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

10.33 / 10.95Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bullish Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

138 / 360 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat